Light Mode
$2.52 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.52, $0.25 below the day’s high of $2.77
+1.29 (+104.88%) / 6M
Momentum, market sentiment, and recent alerts
LUNG reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +27.3%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the following geographical segments: United States, Europe, Middle East, Africa, Asia Pacific, and Other International. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.